Vanda Pharma VNDA reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Vanda Pharma missed estimated earnings by 54.55%, reporting an EPS of $0.05 versus an estimate of $0.11.
Revenue was down $3.51 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 2.04% drop in the share price the next day.
Here's a look at Vanda Pharma's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Vanda Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.